THE ARTEMISININ ENTERPRISE - GHDonline

Benefits of the AE technologies will arise from a variety of direct and indirect factors. For
example, as described in section X, use of higher‐yielding plant varieties would have
multiple benefits, including reduced agricultural production and extraction costs through to
improved environmental footprint of the process. The production of artemisinin by
fermentation bypasses plant production and has the potential significantly to reduce lead
time enabling the market to respond much more rapidly to changing demands. New
antimalarials should also be a useful tool to help mitigate the risk from parasite resistance to
artemisinin. Currently acceleration in the possibility of resistance to ACTs is occurring
through the high use of monotherapies and the widespread availability of substandard
ACTs. With increased availability and cheapness of ACTs made possible through the use of
these new technologies, an added benefit will be the decreased use of monotherapies and
substandard product.
32